Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide ... 50µg/500µg twice daily from a Diskus™ inhaler for a 4-week run ...

Fluticasone propionate, salmeterol (as xinafoate); 45mcg/21mcg ... each given as 2 inhalations twice daily, and with Advair Diskus 500 mcg /50 mcg given as 1 inhalation twice daily in 509 patients ...

Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...

Hikma's filing for a generic version of GlaxoSmithKline's Advair Diskus has been accepted by the FDA. The abbreviated new drug application (ANDA) for the fluticasone propionate and salmeterol ...

Salmeterol (as xinafoate ... All patients were switched to fluticasone propionate 88 mcg twice daily during the 2- to 4-week run-in period. If patients were still not adequately controlled ...

Even though Advair’s main patent expired in 2010 and the patent on the Diskus inhaler expired ... Inhub in three strengths: fluticasone propionate 100 mcg/salmeterol 50 mcg, fluticasone ...